for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Shenzhen Salubris Pharmaceuticals' Controlling Shareholder Plans To Sell 5% Stake To CLSA Asset Management

Sept 1 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd :

* SAYS CONTROLLING SHAREHOLDER PLANS TO SELL 5% STAKE IN THE COMPANY TO CLSA ASSET MANAGEMENT LIMITED FOR 1.78 BILLION YUAN ($260.85 million) Source text in Chinese: bit.ly/2ESKeFq Further company coverage: ($1 = 6.8239 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up